| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 42 |
| 1 | MYCOPHENOLATE MOFETIL | 37 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 37 |
| 3 | RITUXIMAB | 35 |
| 4 | PREDNISOLONE | 29 |
| 5 | PREDNISOLONE ORAL | 29 |
| 6 | PREDNISOLONE ORAL SOLUTION | 29 |
| 7 | PREDNISONE | 25 |
| 8 | TACROLIMUS | 24 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERAVACYCLINE | 1 | 0.0034 |
| 1 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 2 | ONASEMNOGENE ABEPARVOVEC-XIOI | 3 | 0.0013 |
| 3 | COAGULATION FACTOR VIIA (RECOMBINANT) | 3 | 0.0011 |
| 4 | GLYCOPYRROLATE | 4 | 0.0007 |
| 5 | BASILIXIMAB | 8 | 0.0007 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 7 | RISDIPLAM | 2 | 0.0005 |
| 8 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 9 | ETOMIDATE INJECTION | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 80 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 35 |
| 2 | Alkylating Drug [EPC] | 20 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 12 |
| 5 | Loop Diuretic [EPC] | 12 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 7 | Penem Antibacterial [EPC] | 11 |
| 8 | Platinum-based Drug [EPC] | 11 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 2 | Penem Antibacterial [EPC] | 11 | 0.0003 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 8 | Recombinant Human Deoxyribonuclease 1 [EPC] | 4 | 0.0002 |
| 9 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |